RecallRadar

FDA Drug recall D-0533-2026

Primidone Tablets USP, 250mg, 100-count bottle, Rx only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 0527-1231-01

On 2026-05-27 the FDA classified a Class III recall of Primidone Tablets USP, 250mg, 100-count bottle, Rx only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 0527-1231-01 by Lannett, citing cross contamination with other products: API contaminated with trace amounts of Acemetacin API.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0533-2026
ClassificationClass III
Statusongoing
Initiated2026-04-24
Published2026-05-27
Last updated2026-09-13 11:52 UTC
CompanyLannett
DistributionUS

Product

Primidone Tablets USP, 250mg, 100-count bottle, Rx only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 0527-1231-01.

Reason

Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.

Identifiers

ndc0527-1301-01
ndc0527-1301-05
ndc0527-1301-10
ndc0527-1231-01
ndc0527-1231-05
ndc0527-1231-10
code_infoLot#: 25283038A, Exp 1/31/2028; 25283564A, 25283565A, Exp 3/31/2028; 25285712A Exp 08/31/2028; 25284105A, Exp 4/30/2028; 25284874A, 25284875A, Exp 08/31/2028.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0533-2026%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.